The effects of the coronavirus disease 2019 (COVID-19) on young individuals’ alcohol usage and difficulties.
Roche’s Genentech touts label expansion for blockbuster lung cancer drug Alecensa
Roche’s Genentech said that Alecensa scored a label expansion from the FDA, with the drug now approved as an adjuvant treatment following tumor resection in